Komori
Human Metabolome Technologies (6090) · InitiativeRestated

Discontinuation of the Temporary Staffing Business and Concentration of Management Resources

First written in FY2016-Q4. 3 of 4 entries say "Restated". Latest entry: FY2017.

4entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016-Q4 – FY20172016: 220162017: 22017
Same theme, other companies
Discontinuation of the staffing business and restructuring of reporting segmentsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2017RestatedAnnual report

    「The “personnel dispatch business” was discontinued at the end of the previous consolidated fiscal year, and from the current consolidated fiscal year the reported segments were changed from the previous 3 segments, consisting of the “metabolome analysis business,” “biomarker business” and “personnel dispatch business,” to 2 segments, consisting of the “metabolome analysis business” and “biomarker business.”」

    The discontinuation of the personnel dispatch business and the change to 2 segments were also confirmed in the full-year report.
  2. FY2017-Q2RestatedAnnual report

    「Following the discontinuation of the “personnel dispatch business” as of the end of the previous consolidated fiscal year for the purpose of concentrating management resources, the reported segments were changed from the previous 3 segments, consisting of the “metabolome analysis business,” “biomarker business” and “personnel dispatch business,” to 2 segments, consisting of the “metabolome analysis business” and “biomarker business,” from the first quarter.」

    The discontinuation of the personnel dispatch business and the change to 2 segments continue to be reported.
  3. FY2017-Q1RestatedAnnual report

    「Following the discontinuation of the “personnel dispatch business” as of the end of the previous consolidated fiscal year for the purpose of concentrating management resources, the reported segments were changed from the previous 3 segments, consisting of the “metabolome analysis business,” “biomarker business” and “personnel dispatch business,” to 2 segments, consisting of the “metabolome analysis business” and “biomarker business,” from the first quarter.」

    The discontinuation of the personnel dispatch business and the change to 2 segments continue to be reported. No new discontinuation or change is indicated.
  4. FY2016-Q4First statedAnnual report

    「Following the discontinuation of the “personnel dispatch business” as of the end of the previous consolidated fiscal year, 31 March 2016, for the purpose of concentrating management resources, the reported segments were changed from the previous 3 segments, consisting of the “metabolome analysis business,” “biomarker business” and “personnel dispatch business,” to 2 segments, consisting of the “metabolome analysis business” and “biomarker business,” from the first quarter of the current consolidated fiscal year.」

    The personnel dispatch business was discontinued as of 31 March 2016, and the reported segments were changed to 2 segments.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Human Metabolome Technologies yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Discontinuation of the Temporary Staffing Business and Concentration of Management Resources | Human Metabolome Technologies,Inc. (6090) | Komori